EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury

Kang Jun Cho, Mamoru Hashimoto, Sergei Karnup, Kanako Matsuoka, Tadanobu Kamijo, Joon Chul Kim, Jun Sung Koh, Naoki Yoshimura

Neurourology and Urodynamics · 2024

DOI: 10.1002/nau.25458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Kang Jun Cho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Monoacylglycerol Lipases, Spinal Cord Injuries, Mice, Inbred C57BL, Urinary Bladder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Activation of the endocannabinoid system by monoacylglycerol lipase (MAGL) blockade may affect the lower urinary tract function. We investigated the effect of an MAGL inhibitor, MJN110, on neurogenic lower urinary tract dysfunction (LUTD) in the mouse model of spinal cord injury (SCI).

Methods

Female C57BL/6 mice that underwent spinal cord transection at T8–10 level were divided into three groups consisting of (1) vehicle‐treated SCI mice, (2) 5 mg/kg, or (3) 10 mg/kg of MJN110‐treated SCI mice. MJN110 and vehicle were administered intraperitoneally for 7 days from 4 weeks after spinal cord transection. We then conducted awake cystometrograms and compared urodynamic parameters between three groups. The expression of cannabinoid (CB) receptors, TRP receptors, and inflammatory cytokines in L6‐S1 dorsal root ganglia (DRG) or the bladder mucosa were evaluated and compared among three groups. Changes in the level of serum 2‐arachidonoylglycerol (2‐AG) and bladder MAGL were also evaluated.

Results

In the cystometrogram, detrusor overactivity (DO) parameters, such as the number of nonvoiding contraction (NVC), a ratio of time to the 1st NVC to intercontraction interval (ICI), and NVC integrals were improved by MJN110 treatment, and some effects were dose dependent. Although MJN110 did not improve voiding efficiency, it decreased bladder capacity, ICI, and residual urine volume compared to vehicle injection. MJN110 treatment groups had lower CB2, TRPV1, TRPA1, and inflammatory cytokines mRNA levels in DRG and bladder mucosa. Serum 2‐AG was increased, and bladder MAGL was decreased after MAGL inhibitor treatment.

Conclusions

MAGL inhibition improved LUTD including attenuation of DO after SCI. Thus, MAGL can be a therapeutic target for neurogenic LUTD after SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoacylglycerol LipasesSpinal Cord InjuriesMice, Inbred C57BLUrinary BladderUrodynamicsAnimalsFemaleMiceDisease Models, AnimalGanglia, SpinalReceptors, CannabinoidEnzyme InhibitorsEndocannabinoidsCytokinesUrinary Bladder, NeurogenicLower Urinary Tract SymptomsCarbamatesSuccinimides

Stichwörter der Autor:innen

2‐arachidonoylglycerol (2‐AG)endocannabinoidlower urinary tract dysfunctionmonoacylglycerol lipase (MAGL)spinal cord injury

Substanzen

Monoacylglycerol LipasesMJN110Receptors, CannabinoidEnzyme InhibitorsEndocannabinoidsCytokinesCarbamatesSuccinimides

Autor:innen und Institutionen

  • Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Urology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Förderung

  • NIDDK NIH HHS
  • NIH HHS

Zitieren

APA

Cho, K. J., Hashimoto, M., Karnup, S., Matsuoka, K., Kamijo, T., Kim, J. C., Koh, J. S., & Yoshimura, N. (2024). Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25458

Vancouver

Cho KJ, Hashimoto M, Karnup S, Matsuoka K, Kamijo T, Kim JC, et al. Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25458

BibTeX
@article{Cho2024,
  author = {Cho, Kang Jun and Hashimoto, Mamoru and Karnup, Sergei and Matsuoka, Kanako and Kamijo, Tadanobu and Kim, Joon Chul and Koh, Jun Sung and Yoshimura, Naoki},
  title = {Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury},
  journal = {Neurourology and Urodynamics},
  year = {2024},
  doi = {10.1002/nau.25458}
}
Kostenlos starten →